UPDATE: BME Eyes APA Status to Support OTC Transparency Data Services

The exchange will begin offering members the ability to report trades in OTC markets for compliance with MiFID 2.


BME Market Data will apply for authorization from the supervisory authorities to operate as an Approved Publication Arrangement (APA), a new designation introduced by MiFID 2 in the context of the new European post-trade transparency framework.

The idea, says Santiago Ximénez, BME Market Data director general, is to develop new services to help clients comply with the challenges presented under MiFID 2. "We feel that most of our current clients, and potentially new clients, will have to comply

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here